| Patient | Roald Amundsen |
|---|---|
| Date of birth | 1970-07-16 |
| Identifiers | MRN HR-EX003-SYN; SSN (made up) 000-03-1259 |
| Document date | 2026-03-24 |
| Author | Ingrid Solheim-Achebe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-week review of finger pain on capsaicin cream. [S]
Mr. Amundsen returns four weeks after starting capsaicin cream. It stung for the first week and he has used it about three times a day. The burning is a little less, but the cold attacks still come most days in the late winter weather, and his average pain over the past week is 5 of 10. He still wakes some nights. He is willing now to try a tablet if it will not make him drowsy, because he drives and expects to fly again. He drinks rarely and takes no other medicines. [S]
| Element | Detail |
|---|---|
| Finger pain | Average 5 of 10 over the past week |
| Capsaicin cream | About three times a day; stinging in the first week |
| Sleep | Still woken some nights |
| Preference | Will try a tablet that does not cause drowsiness |
| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Burning and numbness of the fingers with cold, slightly less |
| Integumentary | Negative | No skin irritation now; no finger ulcers |
| Psychiatric | Negative | Mood fair |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Capsaicin 0.075% cream, a small amount rubbed into the painful fingers four times a day; wash hands after use and keep away from the eyes | four times a day | Topical route | 2026-02-24 | active | S |
| Duloxetine 30 mg delayed-release capsule, one capsule by mouth daily for one week | once daily for one week | Oral route | 2026-03-24 to 2026-03-31 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-24 | Body height | 183 | cm | S |
| 2026-03-24 | Body weight | 79 | kg | S |
| 2026-03-24 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 2026-03-24 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-03-24 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-03-24 | Heart rate | 62 | /min | S |
| 2026-03-24 | Respiratory rate | 14 | /min | S |
| 2026-03-24 | Body temperature | 36.5 | Cel | S |
| 2026-03-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-24 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | {score} | S |
Vital signs recorded on 2026-03-24; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 126/78, pulse 62, weight 79.0 kg |
| Hands | Fingertips cool; skin intact; no redness from the cream |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Burning pain, numbness and tingling in the fingers of both hands, brought on by cold for many winters and worse this winter, with the fingers turning white then blue then red in the cold; average pain 6 of 10; cause not yet established at intake; nerve conduction studies and neurology consultation requested | resolved | confirmed | R20.2 | S — Synthetic presenting problem anchored to his documented frostbite of the fingers; superseded by the diagnosis at the neurology consultation. |
| Cold-induced neuropathic pain and cold sensitivity of the fingers of both hands, a late sequela of frostbite in early adulthood: small-fiber pattern with normal nerve conduction studies, cold allodynia and reduced pinprick at the fingertips, and cold-induced vasospasm | active | confirmed | M79.2 | S — Synthetic modern diagnosis made at the neurology consultation, linked to his documented frostbite of the fingers. |
| Old fracture of the upper end of the right humerus, set at sea and rehabilitated without surgery: forward flexion and abduction limited to about 120 degrees, without pain at rest | active | confirmed | S42.201S | S — Synthetic modern coding of his documented shoulder fracture; the range of movement is synthetic. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pain severity (0 to 10 numeric rating) and overall improvement | Every review, and early after starting or changing a medicine | Completed today | Average 5 of 10, from 6 |
| Medication safety | Adverse effects, especially drowsiness, dizziness and nausea | Every review, and early after starting or changing a medicine | Completed today | Stinging from capsaicin in the first week only; duloxetine started today |
| Examination | Daily activities and participation: fine hand tasks in the cold, driving, flying | Every review, and early after starting or changing a medicine | Completed today | Still fumbling outdoors; driving safely |
| Survey | Mood (PHQ-9) and anxiety | Every review, and early after starting or changing a medicine | Completed today | Mood fair by interview; PHQ-9 due at the next review |
| Examination | Sleep quality | Every review, and early after starting or changing a medicine | Completed today | Woken some nights |
| Examination | Blood pressure | Before starting duloxetine and periodically on it | Completed today | 126/78 mmHg before starting duloxetine |
| Laboratory | Sodium and liver enzyme (ALT) on duloxetine | Baseline, then once in the first weeks of treatment | Ordered | Baseline at intake (sodium 141 mmol/L, ALT 24 U/L); repeat ordered for two to four weeks after starting |
| Medication safety | Interactions: no tramadol or other serotonergic drugs; caution with oral NSAIDs; alcohol | When starting, then every review | Completed today | No tramadol or other serotonergic drugs; rare alcohol |
| Self-management | Skin of the fingers and cold protection | Every review, and early after starting or changing a medicine | Completed today | Skin intact; cold protection continued |
Goal progress:
Guideline basis: Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024)
Follow-up: Preventive visit in two weeks. Neuropathic pain review in six weeks. Next scheduled visit 2026-04-07: periodic adult preventive visit. [S]